Digital Therapeutic Market is growing with a CAGR of 31.4% by 2026 | Noom (US), Livongo Health (US), Omada Health (US),
Posted by Johnny on March 27th, 2023
The study involved four major activities in estimating the current size of the global digital therapeutics market. Exhaustive secondary research was conducted to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing values with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the total market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments
Get a Sample PDF of Digital Therapeutic (DTx) Market Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=51646724&utm_source=Openpr&utm_medium=referral
The global digital therapeutics market is projected to reach USD 13.1 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 31.4% during the forecast period.
Growth in this market is primarily driven by the increasing incidence of preventable chronic diseases, the need to control healthcare costs, rising focus on preventive healthcare, and rising investments in digital therapeutics.
The digital therapeutics market is a highly diversified and competitive market, with several emerging players. The prominent players in this market include Noom (US), Livongo Health (US), Omada Health (US), WellDoc (US), Pear Therapeutics (US), Akili Interactive Labs (US), Better Therapeutics (US), Happify (US), Kaia Health (Germany), Mango Health (US), Click Therapeutics (US), Canary Health (US), Wellthy Therapeutics (India), Cognoa (US), Ayogo Health (Canada), CogniFit (US), Mindstrong Health (US), 2Morrow (US), and Ginger (US). The players in the market focus on providing effective products to cater to the unmet needs of customers, increase profitability, and gain a competitive edge in the market.
Request for PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724&utm_source=Openpr&utm_medium=referral
The research report categorizes the digital therapeutics market into the following segments and subsegments:
Digital Therapeutics Market, by Sales Channel
• B2C
o Patients
o Caregivers
• B2B
o Providers
o Payers
o Employers
o Pharmaceutical Companies
o Other Buyers
Digital Therapeutics Market, by Application
• Preventive Applications
o Prediabetes
o Obesity
o Nutrition
o Lifestyle Management
o Other Preventive Applications
• Treatment/Care-related Applications
o Diabetes
o CNS Disorders
Mental Health Disorder
Other CNS Disorders
o Chronic Respiratory Disorders
o Musculoskeletal Disorders
o Cardiovascular Diseases
o Smoking Cessation
o Medication Adherence
o Gastrointestinal Disorders
o Substance Use & Addiction Management
o Rehabilitation & Patient Care
o Other Treatment/Care-related Applications
Digital Therapeutics Market, by Region
• North America
o US
o Canada
• Europe
o UK
o Germany
o France
o Spain
o Italy
o Rest of Europe (RoE)
• APAC
o Japan
o China
o India
o Rest of the APAC
• Rest of the World (RoW)
Recent Developments:
• In April 2021, Welldoc(US) partnered with Dexacom (US). This partnership helped provide BlueStar with Dexcom G6 CGM as a single platform to people with Type 2 diabetes for improved health.
• In March 2021, Pear Therapeutics (US) partnered with Sprectrum Health Systems (US). Tufts Health Plan and Spectrum Health Systems announced a collaboration with Pear Therapeutics to test FDA-approved digital therapeutics to help people with substance use disorders and improve their recovery journeys by delivering solutions for improved treatment access and care innovation journeys by delivering solutions for improved treatment access and care innovation
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=51646724&utm_source=Openpr&utm_medium=referral
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
